0001628280-21-000921.txt : 20210128 0001628280-21-000921.hdr.sgml : 20210128 20210127200748 ACCESSION NUMBER: 0001628280-21-000921 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210122 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210128 DATE AS OF CHANGE: 20210127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 21561597 BUSINESS ADDRESS: STREET 1: 7000 MARINA BLVD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 7000 MARINA BLVD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC DATE OF NAME CHANGE: 20000208 8-K 1 sgmo-20210122.htm 8-K sgmo-20210122
January 22, 20210001001233false00010012332021-01-222021-01-2200010012332020-11-042020-11-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 22, 2021

 
 SANGAMO THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
  
Delaware 000-30171 68-0359556
(State or other jurisdiction of
incorporation)
 (Commission
File Number)
 (IRS Employer
ID Number)
7000 Marina Blvd., Brisbane, California 94005
(Address of principal executive offices) (Zip Code)
(510) 970-6000
(Registrant’s telephone number, including area code) 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report) 
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value per share SGMO Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  




Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously announced by Sangamo Therapeutics, Inc. (“Sangamo”) on January 6, 2021, Sung Lee, Executive Vice President, Chief Financial Officer and Principal Financial Officer of Sangamo, notified Sangamo of his resignation from these positions and from his employment with Sangamo, in each case to be effective on February 1, 2021.

On January 22, 2021, Sangamo and Mr. Lee entered into a letter agreement (the “Letter Agreement”) pursuant to which Mr. Lee agreed to provide services to Sangamo in an independent contractor role for the period from February 2, 2021 through February 26, 2021. In this role during this period, Mr. Lee will no longer serve as Sangamo's Chief Financial Officer but will continue to serve as and perform the functions of Sangamo’s Principal Financial Officer in a consulting capacity and will consult for Sangamo on transition activities related to Sangamo’s financial matters, including the filing of Sangamo’s Annual Report on Form 10-K for the year ended December 31, 2020. Mr. Lee’s compensation for this independent contractor role will consist solely of a payment of $215,000, payable in one lump sum on February 26, 2021, which shall be deemed to be the annual cash bonus payable to him under Sangamo’s Amended and Restated Incentive Compensation Plan, subject to legally required withholdings. The foregoing description of the terms of the Letter Agreement is not intended to be complete and is qualified in its entirety by reference to the Letter Agreement, a copy of which is included hereto as Exhibit 10.1 and incorporated herein by reference.


Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Number
Description
10.1
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  SANGAMO THERAPEUTICS, INC.
Dated: January 28, 2021  By: /s/ Gary H. Loeb
  Name: Gary H. Loeb
  Title: Executive Vice President & General Counsel


EX-10.1 2 leeconsultingagreementfinal.htm EX-10.1 Document


Exhibit 10.1


January 22, 2021

Mr. Sung Lee
Dear Sung:
Your last day as a Sangamo employee will be February 1, 2021 (“Separation Date”). We are sad to see you leave Sangamo, but are grateful for your time of accomplished service. We are also pleased that you are willing to continue working with Sangamo in an independent contractor role for the period from February 2, 2021 through February 26, 2021. This letter agreement is intended to memorialize your independent contractor arrangement with Sangamo.

1.Terms of Relationship between Sangamo and You. You and Sangamo agree that the work relationship between the parties from February 2, 2021 through and including February 26, 2021 will be the following:

a.After the Separation Date, you will be an independent contractor of Sangamo and will not be an employee, agent, joint venture or partner of Sangamo. Sangamo shall not obtain or carry workers’ compensation insurance on your behalf. In the event of any claim or proceeding by any state or federal taxing authority, you agree to indemnify, defend, and hold harmless Sangamo from any claims, penalties, or assessments by state or federal taxing authorities.

b.You will be provided with a payment of $215,000, which shall be deemed as your annual bonus payable under Sangamo’s incentive plan, payable in one lump sum on February 26, 2021 and subject to all legally required withholdings and any authorized deductions. No overtime, expenses, costs or other fees shall be earned for any work performed under this letter agreement. You agree that other than as explicitly set forth in this Section 1.b and Section 5 below, you shall have no entitlement to compensation of any sort from Sangamo, including but not limited to claims to salary, bonus or equity awards, notwithstanding the terms of any other agreement between you and Sangamo or any plans or programs maintained by Sangamo.

c.After the Separation Date, you will not be entitled to participate in any benefits provided by Sangamo for its employees, including but not limited to paid vacation, sick leave, medical insurance, and 401(k) and employee stock purchase plan participation.

d.You affirm that as an independent contractor you will hold Sangamo’s business, research and development, intellectual property, trade secrets, and other confidential and proprietary information in strictest confidence, as detailed in Section 4. You further agree that you will make every effort to limit your access to Sangamo confidential and proprietary information except as necessary for the performance of services set forth in Section 3.

2.Term of Agreement. This letter agreement is effective beginning on February 2, 2021, and will continue until February 26, 2021.

3.Services to be Performed by You. Your work shall consist of transition activities related to Sangamo’s financial department activities and to Sangamo’s filing of its 10-K annual report. You will no longer be Chief Financial Officer but you have agreed to serve as consultant/principal financial officer for purposes of Sangamo’s February 2021 activities and filings. As principal financial officer, you agree to take all steps necessary to prudently perform your duties. For the purposes of this letter agreement, the activities described in the foregoing sentences shall be the “Services” as such term may be used herein. Dr. Sandy Macrae shall serve as your manager under this independent contracting arrangement. In the performance of your Services as set forth in this letter agreement, the hours and work on any given day shall be entirely within your control. Sangamo acknowledges that you will be employed by another company at the time of these Services and does not anticipate conflicting in any way with your duties to this new employer.

4.Non-Disclosure of Confidential Information and Non-Solicitation of Employees. You and Sangamo agree that the aspects of your employment agreement agreed upon in the Proprietary Information, Inventions and Materials Agreement signed by you and Sangamo on or about your employment




start date, as may have been amended from time to time, covering certain confidential information and invention assignments (“Confidential Information Agreement”) shall remain in full force and effect during the term of this letter agreement and shall apply to the independent contractor relationship between you and Sangamo except that, notwithstanding anything in the Confidential Information Agreement:

a.At-Will Employment. As set forth in this letter agreement, you will be an independent contractor of Sangamo, and not an employee.

b.Inventions. To the extent the terms of the Confidential Information Agreement apply to your work as an independent contractor of Sangamo, any such terms related to any improvements, inventions, works of authorship, mask works, computer programs, formulas, ideas, processes, techniques, know-how and data, whether or not patentable, made or conceived or reduced to practice or developed by you, either alone or jointly with others (“Inventions”) shall apply only to Inventions which you conceive, develop or reduce to practice, or cause to be conceived or developed or reduced to practice, during the course of performance of the Services for Sangamo hereunder.
You acknowledge and reaffirm your obligation to keep confidential all non-public information concerning Sangamo that you acquired during the course of your employment with Sangamo as stated more fully in the Confidential Information Agreement. You further acknowledge and reaffirm your other obligations under the Confidential Information Agreement, which also remain in full force and effect during the term of this letter agreement, or as may otherwise survive in accordance with the terms of the Confidential Information Agreement. Nothing in this letter agreement or the Confidential Information Agreement is intended to interfere with or discourage a good faith disclosure to any governmental entity related to a suspected violation of the law. You cannot and will not be held criminally or civilly liable under any federal or state trade secret law for disclosing otherwise protected trade secrets and/or confidential or proprietary information as long as the disclosure is made in (i) confidence to a federal, state, or local government official, directly or indirectly, or to an attorney and solely for the purpose of reporting or investigating a suspected violation of law; or (ii) a complaint or other document filed in a lawsuit or other proceeding, as long as such filing is made under seal.

5.Sangamo’s Equity Plans. On and prior to February 1, 2021, you were a participant in Sangamo’s equity incentive plans (collectively, the “Plans”). You agree that notwithstanding any other terms in your employment relationship, Sangamo’s Plans or any applicable award agreements, (i) the vesting of any stock options or other equity awards issued to you under the Plans shall cease on February 1, 2021, the last day of your employment with Sangamo, and (ii) for purposes of determining the post-termination exercise period of your stock options, your “Continuous Service” (or any analogous term) shall be deemed to cease on February 26, 2021, the last day of the term of this letter agreement. For the avoidance of doubt, this means that so long as your service continues through February 26, 2021, you shall have through at least May 27, 2021 to exercise your vested stock options. This clause expressly supersedes any prior agreement you may have had with Sangamo regarding your equity awards.

6.Return of Sangamo Property. On or before the last day of the term of this letter agreement, you agree to return to Sangamo in good working order all keys, files, records (and copies thereof), equipment (including, but not limited to, computer hardware, software and printers, wireless handheld devices, cellular phones and pagers), access or credit cards, Sangamo identification, documents and any materials of any kind that contain or embody any proprietary or confidential information of Sangamo (and all reproductions thereof in whole or in part) and any other Sangamo-owned property in your possession or control and you must leave intact all electronic Sangamo documents, including, but not limited to, those that you developed or helped to develop during your employment. You agree that you will make a diligent search to locate any such documents, property and information on or before this letter agreement terminates or expires. In addition, if you have used any non-Sangamo computer, server, or e-mail system to receive, store, review, prepare or transmit any Sangamo confidential or proprietary data, materials or information, you agree to provide Sangamo with a computer-useable copy of such information and then permanently delete and expunge such Sangamo confidential or proprietary information from those systems. You further agree to provide Sangamo access to such systems as requested to verify that the necessary copying and/or deletion is completed. You agree that, after the termination or expiration of this letter agreement, you will neither use nor possess Sangamo property. By the termination or expiration of this letter agreement, you must also cancel all accounts for your benefit, if any, in the Sangamo’s name, including, but not limited to, credit cards, telephone charge cards, cellular phone and/or pager accounts and computer accounts.

7.Applicable Law; Entire Agreement. This letter agreement shall be interpreted and construed by the laws of the State of California, without regard to conflict of laws provisions. This letter agreement, together with the Confidential Information Agreement and the Plans, contains and constitutes the entire




understanding and agreement between the parties hereto with respect to your independent contracting arrangement with Sangamo and the other matters herein.





If you have any questions about this letter agreement, please call Whitney Jones at (xxx) xxx-xxxx.

Very truly yours,

By:    /s/ Whitney Jones    
Whitney Jones, Chief People Officer


I hereby agree to all the terms and conditions set forth above.


/s/ Sung Lee                    Date: January 22, 2021
Sung Lee


EX-101.SCH 3 sgmo-20210122.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 sgmo-20210122_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 sgmo-20210122_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 sgmo-20210122_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 sgmo-20210122_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 sgmo-20210122_htm.xml IDEA: XBRL DOCUMENT 0001001233 2021-01-22 2021-01-22 0001001233 2020-11-04 2020-11-04 2021-01-22 0001001233 false 8-K 2021-01-22 SANGAMO THERAPEUTICS, INC. DE 000-30171 68-0359556 7000 Marina Blvd. Brisbane CA 94005 510 970-6000 false false false false Common Stock, $0.01 par value per share SGMO NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover Page Cover Page
Jan. 22, 2021
Nov. 04, 2020
Cover [Abstract]    
Document Type 8-K  
Document Period End Date Jan. 22, 2021  
Entity Registrant Name SANGAMO THERAPEUTICS, INC.  
Entity Incorporation, State or Country Code DE  
Entity File Number 000-30171  
Entity Tax Identification Number 68-0359556  
Entity Address, Address Line One 7000 Marina Blvd.  
Entity Address, City or Town Brisbane  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94005  
City Area Code 510  
Local Phone Number 970-6000  
Written Communications false  
Soliciting Material false  
Pre-commencement Tender Offer false  
Pre-commencement Issuer Tender Offer false  
Title of 12(b) Security Common Stock, $0.01 par value per share  
Trading Symbol SGMO  
Security Exchange Name NASDAQ  
Entity Emerging Growth Company false  
Entity Central Index Key   0001001233
Amendment Flag   false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 2 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Page Cover Page Sheet http://www.sangamo.com/role/CoverPageCoverPage Cover Page Cover Page Cover 1 false false All Reports Book All Reports sgmo-20210122.htm leeconsultingagreementfinal.htm sgmo-20210122.xsd sgmo-20210122_cal.xml sgmo-20210122_def.xml sgmo-20210122_lab.xml sgmo-20210122_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sgmo-20210122.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 2, "dts": { "calculationLink": { "local": [ "sgmo-20210122_cal.xml" ] }, "definitionLink": { "local": [ "sgmo-20210122_def.xml" ] }, "inline": { "local": [ "sgmo-20210122.htm" ] }, "labelLink": { "local": [ "sgmo-20210122_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "sgmo-20210122_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "sgmo-20210122.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sgmo", "nsuri": "http://www.sangamo.com/20210122", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sgmo-20210122.htm", "contextRef": "i3394f5260f7240e987f7eead7348c535_D20210122-20210122", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page Cover Page", "role": "http://www.sangamo.com/role/CoverPageCoverPage", "shortName": "Cover Page Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sgmo-20210122.htm", "contextRef": "i3394f5260f7240e987f7eead7348c535_D20210122-20210122", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.sangamo.com/role/CoverPageCoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0001628280-21-000921-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-21-000921-xbrl.zip M4$L#!!0 ( />@.U))PPG?[A( "E: ? ;&5E8V]NU[ M39IILC?33SL0"4JH*8(+@);5O_Z>!T!2KUCNNI&FOO[T6OS/IW<_B'%_,!2? MK"R=]MJ4LC@]??/^1)S,O*^N3D\7BT5_<=8W=GKZZ:=3'&I\6ACC5#_SV_FG%W_N]<1KD]9S57J16B6]RD3M=#D5GS/EKD6O%^YZ9:JEU=.9 M%Z/!:"@^&WNM;R1?]]H7ZF4C"YF= MI^GE0)V-)UG^;'#Y;)R/AY/T?#3(U-F_A[#(4[B=GW%^6:B_G\QUV9LIG/]J M^*SRSQ)K/P,']LQMAY;6.62F89T-XK5.ZOGL(T M\0>B_*HWONR?P:]>W?J>+/2TO*(+)SQ#'"4UA;%7CP;TWW.\TLOE7!?+J[]] MTG/EQ'NU$#^9N2S_ECC8QIY35N=\H]._JJOA$":AKPLF>0SC%+I4#0M&2/>; MVYF>:"^&@_YP@^C[D73R)?X=>JB'X^M@+[[^0Y:UM$LQ&B4D[/L+5%=@I9V" MS'I370WZ@_,.B;MH/AL/SB^? M[T/5L'^^!U7#IWP;V0%=9F#TKLZ>'DQ>?S:U%85T7F1R*:034GR4Y53.C5#S MJC!+V-*%+@HQ4>)[-;$DW$.6;?'XFT>7H]'@^4=522O1H8C7X 7HU^'S)WWQ M60EIE7 R$]X(!V,M32T*)6]4G"81D]K375,80N5U(7)C\3XK/% J3"YDFAI8 MC'8S\#! Z(U.53.X+)P1%8SIX**?24]SX!5<-WHCF#H%1NBRAM_0]\!O"^UG M#:6Z%+(4N!F5HAVA^ZU,/:S$FD+1DOQ,B0JX;#*16S-OV1%4'6ZPII[..A>> M\I6^^#33#NCV7EDAIU8IGJW)],7H8#(MOY),;YM]3:;/ M^H,+Y,.W.9HPW*0UHY^0V8V[N-N<@CYT19\>*(T/#T6?DX (PH.)^,6 A10W M\+D&BP[/H[25JCM.OQG0S608S4R\!*L.]Z=@+9 MEZX&@YK"\"7;W8F"@?*^>,L"KG!Z\D/E4J2%U'-:B#6I4B3-DR5=1*\N^I?'HUF3X]&LX"U^ M[F@/B-:-1E! WEV"S"_G003_,AJ>)["Z1"QF.IT%D8=G,L04&2(X$F%90AP" M%TQ9.WQ>3@#%U,!W&R4JZ )"D!0&UP#)JD*627,WZD^I1%'/*^'J.6K'IME& M@77UY!>5>A1I7$RAIO#/$AS&?VIM Q4HU$"SHP=0C(,D_@K7@=(Z)=?2%^*] M$>9&681^B5"WJ*8HXJEQ(-EH/T C4:QA-QK: :J7, Z"-!R:W!4@-?B.+&&J M_38$!O/]W&HDNCL>'CZ6R$J8O]"I]D"-4QXG@/W0)0_V4=&BQ; _8><9OI_# MDL!]L;+S&F<(>$N U"6E-V@S"95VS%"P+P[F8&5O '+K-A$JHWDK]%Q[!HUL M#@A>RP*V)@E[#KQ _GO@]$+:#%@(#^).@&DH:3 T;3YB%)R::6_A:73RRS5T M$-B,TN*")03L#N/,P>:BW865@0V*YGD_.W.VKYVY=QPY?-9_MIIX^:5V'LSN ML1BC]'B,T7W*ZJ;3J# MH)'DN+-R&'E39!_ 9Z-2,:/1>BRXQ&ZC@>4>:[MG$TQ)B-VPLA&"@DMK;NT M"::A 0\EX(0<>(>4XX\,D%QAJCDA2XR\BP)L-OI)$$YP&(C08((,1$2E5GG' M,L1V$2;/-2X#(G3Z&9^Q6GGTA[I$9Q/Q)'#3ZM0KYYNG2!X=K #L(RH+W!3] MQ;A/3BBO;6M_VT0&$3F7UP1#82:5HQ="92"]"-X^31$KPH]1L_9>K;I-547, M+A4.@M<[V0ZZD;!Q'C,O;M471C+.]C3TH]]BYX=WFWD0H\$1)=9&1YF/P&W\ MMD4_A\PY[$R)@82C2 %BFBB0@!)]P0KV9.B9M/%CD]VKX=]B6_YMS\S8AIB- M1[OD[$$R:(,6F1Q>8L^.3F(_1H,#A@V0QH<&T@.$.(:50@S$^"*'3CH(T MWQ18P3*#)%.\S0DTQC'K_BK7)1A9--49PBU/JM!Y%"5]ZV.4WX89$40-![U_ MQKC/J@KL(''?.LI91\>@G<3.<5U77HR%VM#5J&(1RP:VQZ\QJ2H8(\7UT>ITU;PT: M$[JML^!,N=3J"7MUSE]:-36X-4YA?C_M!JMX0ZB;_,[B2R->:0]!3WJG!K;: M=DBE"J4C%#57 VK#^!30#X81HL8"#R DI&TI[9&;$R2=%M2 MM%908/LEB3N3 <&$W!PY54 M=6OS&."^P$HL*6.B0S*2EVD*$-$F<9I>EV8!,'**MG$%*>(H'.=DG):,X'5> M4=:%$_JQL :?G>K0A!C9P <,NT#'8RB'8!)DB!@5PKJ%Y%5VE8@T$-E0@C"$ M5=BOG&8\KJ+4^.A&_F5X/V$3EQIJC]YB-W-#?QWYEM56^J>A.KY'5/8G[H2A9@!MS)\35;L14X MD-([D!ULI_ <\J/W(C@UP5RJG'.YGS*\9(;1:%*R.\6\-YI8P#54O5J)X?6: M9NHHCECZ ;GCTL_CHT06.TU,HSI'@#F>!#]L%::QT1SD=4'-**GB_"'%I>#K M;#=[OA,F;SP2TC:IA&2W8WU^]1 M7G\P_SSN'U$2]'Z/$WU8[V*1UMHLD_5S ]>T7.LA=$L5/"*'$MH%B['4G4\PUBL]UOYQTHSZ1X# 5 '4[@EEE0;Y)D)I+F44V$ M=U 73XAKN9QRK%"EE=\C@B0LBJ9D>>P$(MP#@I8V[E,2=Z/=K^YV)=P253L5 MQ=[@\BUZJ77Z:=S4W# =>D MYO:9*?8\4: M;PL6S+Y,6&\:Q\\V5S:L#K58.]QXB3L@I@;;U25>RMJT3W!$4XPX*7*$V:B/ M8[GBJX -E$6!KS?:%$T&"%=:R$4H+Z2R9-2VVLTY4T4F4JOGNJ1V,#0\^D;C MQT)WVM%P(;%+T=C0N=BMPN-49$<" 53R:'8*O)WG):Y4[G$Y5*(P:Y5[[E?: M6@H'*< *"?Z+%';XI1T[1-B^Q_I)IZC/; K+3WCQ)%&%P6:4EL%HGT1T@.>*-62(TA38$8X7ZU.X"YPC8>X80E%.$]JA13LVCE@ M)01]SY[C(X\UD"()4A38N-5VUV7Q5%\>>Q4D/NEJW;FI[7]-NIPCV!,*4Y%M MO-%.R6)//#]\N*;3(RJPGA]=-GB])O>&.P8_8&??8?'[CV7H6M&L%NMGCT)\ MB79/MLU;:![+C4ICZ(-<[7,% JT%-QI@.IWM'4YVHUC0*/]]6;9+1FHV$!+ M#C*6L#K HYOF2C9VZD-L*:5:587-M^0IJ(6U]980S: 9QATCJ\JOEXGFRE[:01//9^X<3<'=B*DQID:=?K MX9E")NDRHA2XX'O\4^S,4C8E%\>'SN)4*S0F_%L07( /V AC:A<1>"RH/HY, M!6=LIG@#3O5DHW\<.XHW2(]]-)NTWPFO.H5U>6-T%H.$S-03*H^BCU#(=Y(H M ';1D3"M3$73X>-V'[+;Z+=N3AYY[!&%-;^#-8\NXKDDTS*8ID))PN.%7>[" MZJE-*2TH9%*WE87(&KO!:]@4!V[?<2LTF:D6S>%*FKS_3&:K>-NJ*<@A[CN+ M3EDQNACL1K/CTZK_F3\K4MNR>9/H3VT<,F9G^D(N-$ M8?O)_35UK97&,I&=EE*PYA1-Q".T$!51CJ> (':)B2@ B]1QB_$2N%>T?*FI MJ#$ 0W^3/TE(V*D!%XQB[/1.MK1Z=U)=,] +T W U<[D?D%G?AD:8.B#63-L MFL#^UQG\3F%'IBC[ (.HHJ@+"99W9LK0X8!E3.M@+:%K%B,$")P!VZ9\4*(A MF&(&@.VA AQA<7N(9=X4@8/_ <:$0\AHL<(1-#7'UU@$0]&&'NN123<4Z<@6 M\9$+4_!T/"D368J[LICA$64* @@*/6G6Q]XOC-0S"ZQ.QU;GQCN#X\&S8YIK MU*';A(8@,U8['TYLX^$.B*QQ+0J!DS6E3IMU-MSI]/!OWUD_PPBFR5RL9)U@ M^RIV0S&/%0+Y-2^[>7)GM5E:0IA5Z"E5Y;D!'#NF(2CSJLW.=I;<<(5KJYV= M6%6J;;%[=-J*3]W<5B"/CKJ(T'JP[.B\[:NC1B9$>Y@LQ8.J M-Y>Z$&X)KFG.6AFR?."F4",L"+I:X/*Q;Y"$@)H/L3,<9]C:#KX6 G,NN"/* MMLN -;,03G$T X<3:G'U/:"-$!LH/ID=XO-Z[1JDLD14 S:/._(RD"W M55U.%3^XS_*[@W-5G<2+>>:V]M9ODM$VT-.\X6&$(7B*C9$!7,0"?;YLFTS: M!D.DER%PDW8@HNA @.,@&TC,UC$T6*'FJ$T7_$5!ZN1$V LV7.1@F\ 60F_KQK[[E:0R6\7R9XIN)?XZ]=.39QS>OM(4-;% MT:&L;]OP[X>8M7I##9+'T3:RZZ4>341%\ 0,LR=KGU'OM+"4+#4I4:JS/@4ICQQ@'#.$])M2)&7)YX52=XUAEZWI 7;:8Z)DXAF7$N(]K5G9!?:5O^_C^WA^]B"D3B03:#,2">YDVTY&]Q] 0@B M4A\@ 2"@*IP)W_DJF[6^Z[6B5!! AK @GXCU8_OW Q\I7M^%/_!#7UN&WG9P M+P)2 E/<1$O-L#N !K_/"1P[F-+/,^VQ&O(/CN @VB\PXO/E*.J65E#\3D_\6#H>!:"FJ_@)#X8;NFUMSS9NKI MV67_8AW+],Z&_?'A;-=W2VIN_.;1\.E@R]\#GGTF)F68)"&?>T56%N_"1#O M54=_5Z7^+C*^O&7#R\%>6W9 ^+E";1*.IWU0!NQ /)MVKS/Y]VP&'!_2S;XE MKX:'=6)TBE:O;3,(D(LS"=W>2["@-ULZ)!^0+]V4\G&J27SOY"X-N>_?P];9 M[K=6?M7 M_P=02P,$% @ ]Z [4HW);/^=%P KJ8 !$ !S9VUO+3(P,C$P,3(R M+FAT;>U=:7?:R-+^/K^B7^:^]SKG6*!]P8GO<0SVD+%$;&,S\"6GI6Z!L!9& M$C;PZV]U"S VWN)X8^R*:)RCW93BG!)T$>1]U"8T.T-^FD2HG:1GP3D6!%YG-QE. MTJ#7SY$LRM*UAVG5]0U)ERU#P*ZH"BK5+,'2L"R8Q/>I1ZBO8&.S5_5-PU5$ M31$LPHJIBBZ8GB4)JJ2I+I$L25*\35+5-:I[INX9FDM58NBN+$F:1135,E2= M^A+KMI_#[&"&<58=9\&74C_/A]5*Y>+BHGRAE).T5Y%%4:K\91\<>WT:82&( MLQS''BW-:A%Z66OLIF$YHUZYEYQ7X '4E2Q!E 1%FA8G:81S6';6CB:(YE([8RAZ=M-P)^SB;*GU_.;2]RV1+,@Z;Z0:XKCW MI41CX>2X!&2FF&Q_CFB.$6M6H'^/@O,OI=TDSH%YA=9D"'U[Q;IJB_:C-A[(84PD5RP&UQWF5@#A&T&*?X,F$XI3&)13C MB V-!M6YW'Z'GA-2CTD-BI=00* R44XG;BTY/Y"/SCN*/2*#^GEWWQHT!QVI MV^H.FK7NP)F>!MW6T9DS[0;VH#YV6N&9/3W4G.FAW&UWQ@>*$W:FB>RT3^3. MM ?_>U(G.A&[-4_N#!ICNW6B=6NVV&QYHA.=1O:I*1[(W4FG[>G.H*/:^_5Q MLW44-OSN-R0;^FVV#A5[VE"[^_6+9LT[)_M[@;M_HG?;MMRLG4V@ M/\5IU66GUC]KPK-.RY:[45V".E-GT+CH1HU9G5/H2XN[K2&,LZ,V6PV8FR?9 MK8X(?:J=]K>^/>U&G=;)U![8LCWX&G5"UO.![A=()D>9.#WN?*%:K?R02&9DD^L61# MQY+JB2*V/$ESL:B[5-=]8G F$"4)4'#^89G(]1B8=+(+9$YQV(@)'?]))Q]$ MOH_(TV4BZ[Z'%<_T!=4PL:":Q!),@UJ"3*BN8HE@U?=*VR(H"?A/5I07).\. M"#!A0KP7XMX'6>\CJ[A,5M&R-$_TJ2 1SQ14T9<%;&!/$%W#,'51$>>K:/ MPXRN4+1R%<%3ZE- 5X]F-R@>IMFJ&3<=@.:(*^9J#NKF2RD+HF'(5![_K9\R MEKBB8\KC#/#C<^5J&T7_EYW.QI EHY1_XYJ\.N.S@BD>HTOF#5&.(?-O 6'? M_8"FB ^(WFC([#;^O"H2URMOSW^ZVOJ0*Z/Y-S XTIRII6TV*&9&,;5[_=EB MF.26HO,G\^_S3BI7%NK&=7N,?+ZQ=1,%"=9#?9X__D$K+=6:&5!3$0I\RGZ&JZ,-\ZR(@>;\*2_3_)5YN^W,VQ"") M;EJ!VL7GHI&5IICE+<"@4^SEU6P41:"7M^"O'G21)\.J"LVS20DX#'IQU8-5 MIFFIZ&#>AI>$25K]7>1_MGQ8!<''41!.JO]I!1%@@$,OT%$2X?@_FQE8J-!G M&OA%P2R8TJID0B_\ZT4Q*P/:85;M?);%U$Z<1JM>0\>MG5;]^.J\EF;T5D9[ M7-\].6JT&O5CM./44/VOW3]VG/TZVFW:=N/XN-%T7G$*\H.FT,99/XA[>1)O MHEIYMPS&FJ9:*\-^ZL&)UP:GWCBX?_\NZ>+6*Z[ADPQS2=1X@V^%>_>:1S9Z MCKHM \GW=:W0:=U&CBU'M3KJBL6>LI-MAWSO3H MS&X?]>W]QD5',E6G]T,W+%&QJ")XQ 4W"1--P!I5!4(,XLO$=35)*6V;PI_7 M#2WT(7QK+7P/PUU0'$=UIX6.ZM^;1ZTWKR:^C])LA.,%HATO1_!8LA1U[5B)V:ML\$=T MF*0YVIA_IQ@L5IKEB)ZS4'7*'U/RJ?KTH+_6$;B7U@X3>_J34;1"U&X-I?TJ MP][D17RHG9\9YI..0%8?)/;/:+D5$=0CV@LRMM^0._#DW#R[=A-U/JC?K3SO7[2:NP>;Z*&LUN^35!? M@U]7K>#A<$8\@/E9E,BRRJ:F,(C(4_B?S)N?Q9#*'#TJ.5E]IHAEW9!N?2R6 M'_=,+DNJ_*B:_ZS!J@]JML*IELX+S/E,*_B% -*'C,&^E)32O,P0$Q+$O:J( M)%YJWL?:%)W-^;XZ\G#,:JU:,C<(PRO!V'/:UBR2RX+9.1VFR3E#RJO&=:&W M&[&7I&#K\PR!8U9Z-QG%>3K93#YC[,*0(S .K; MM;T!S$%T]DRV4;;8,".J:E+#< 5#\7U!]>&3:VF>8("CZ%'=\BT#@P=&0WP! MGLZMEOG]TG #9X?4SZ_S=:$[WH3-^[A)_>/%];HT[@4AA=9=L*L^1.]^T6M< M[E5CW:*4F(+B62P%P5! ]'Q-P+I,/*KJ1'1EOF\H**)DW.X5?\C>NY6]%AXW M9KO('M>&'X+X8$$\7 BB[&D2<74LZ);J":JH*X*EF))@8-V@E@AFK626MG53 M$!7-TC3]3DE\:D/O>83R81MH&]RX8O'O)._3% U&:9"1@$?'P87E4;5@V1C[ MM"Z@='W^+XU)KTK5W22*@HPE?G,*,@6."N#XH-\ZT*]Q=(SJT3!,)C3E%&S4 M;J0?AZ(*CZ6\B=V>-Z(T=PA):9;-_CF 4AKJ3!_(?8[L,<_/-53J*II0$5) M%U0,GA]6J2=HOF:X6/=T;!FE;:"1B&R98J^):D"D21#4'7+$K"/74$GJF]2HA-B@+?P%12TB^,51_T9 MJ/3389L9&;E-T4R_0\F GSQY3[2P&P[4-K/V2T%W\D%3L2KZ,0=2H*:B> M =ZY)ZJ")2DZ55Q3D66]M&V!]:'=G^7T8OM1#S0C9D1F>U%#P'T 0R & ?4%*:.=E**WY]L3)LM^X)UP?CTG/!UD("-_KV?Q.LF<\^1,/P08'?^ MAC"?/K0!8^KWF_N'8V>Z-[#E$Q7L';E9VQEW0O-B.8-!-8B.-5T5?!4;[-80 M!>P=PQ<41;)<#?N^IWI,W"U#5;>>?Q/U)78;;V;C&3/!'):Y"0V73C8]!O>.;L-Z;V-!S8[1.UVZY/6?]\C(.5K? QU!,[ M+1A7^W30;!^*G8$];;;M<;?5#SLM!^9Z(L'O$V?O*IA24]8]V=,%43$M0=5< M+ #;F8*F^)2ZEJ9A#[\@F+YJ1LHE,Z%HQDVK8"JI6)#D)3R]@"7RH;T4WG-'P#^> #_GE)F#+,;4/C):N:: MIDW?7]-(WCRGZ1"LX*]G[+(;IWUXX=1.P<(-P^[@9-QI?PL[$?P^[5QT6IW5 MG*9:OV_O'\KV8$?JUG9$I[T7-=NGD=/:ZW>BTZ SV%&^<\TJ)E37&$@+ MJN%C0;4L3W EGUVE)LJFJLNJ[!OO!E%T_ M2UDK2X;V.*"5'FC2_B30Z@\TP#^ ]JF!MI%E(YK^,^#69FF@+>BKU;FP!XV) MLP_C:N\-G!I [GY==?:=?F?Z[)_P&WM\&M M0@5UPWL8W,[*OET[>BF@4L3&:4K)E4E?O5^"*YI9P!QFNQH?7Y\0BFR4),]IV:T4\X2#XTGD)N%&]I%+OP9$D5VKCYNU0YGMB7;D0W W#B?-&CES:HTI MC"'H1-W0GNZQ,4Z6W0U7E&67ZJX@ZE@45/";!=?W1,'0?=$T#%UR%;6TS1P\ M8.7C//'.-M&_Q+(HH2%.T3D.1Q0-V:6U_8]#W1]B^W"QG>FX0L5]R.P#9/;R MN+=E$$4V)%^0587EDHOLO TQ!$J()6)?TDW1!>]QWVY^".2'0/Y4E(\9+JNG M;N8Z=AY+6=M+SEY:9B]/AA/9E4$P54$RX"\5&Z: -5\1%,LS31=DV'(59D1F M!/^-]L/$Q2$ZIB'U"/)YD"N,Z _.8 M\A/AUS) @PS!$"G,M<=B"7W)6Y"*)&EJ]M?3R MLE(%;3"X,&8WC_&LI'F5@%^2-F27I+%,XR*4*+N"?$.+-]V#>JUI%ER\K+W4 M>/GVG/BW0:/ZS>M]TY5M[VR7HSC--E^??;X\N\7JK"42/OIDR-BNG8Q_*)YG M4)?Z@D4-@#-))()ER*9 7<,TB(9E4[U_E^(U./RM2V##OP/WV&F4&T$T6,F@ M[P-$"B1FEJ?/7I 6\!3\XMT=3!QX7^&$=<[?U,?@-H:Y MP9.4G@<9U /@Q;''Y!I['KLOC15F;W\C."59D:%/[MRI4#;P8J=B&5#+;P9I M%JS[%EEU^6TGPZ0@836E(6;'+5?>?W)I!//M'O&R"G;!$A[EMU?YF6N0E__N MIY?N1(\*;DKQF8!]:*"*PPL\R4J5YWJ%R\UB_$KW-J]8\1)+DVCD-$):692? MA[ONO0J=#P*Q/R_#WCPQSU9 M-EQ& )>AV:JLE@UM17>XV#L#(!_%1)@MKL__;+T DO"EWF&@#.!=',;"<0QC M\0"@08D M7+.^B8Y'H (.*-T$.)\?^SZ%547?4YKQUU-MHMU^0'VTMU >LW6'\1 H-C\V MOOH<2#4;PB939<7=QO-QPT-F8;->>G%QG(R_518T"ZB[.=)EO!/^@)6F_,H; MSC9?.\(7[<<&9R()C0.;MJ@%L!#^,>UD4V"KF9Z^$A]L 3Y#W,^V-JXQPX]Y'D_(7X)]R9^+45Q:U>"1@BADRV?/EP_.KDY@)P9I#.=O-6$X MQ>8MB>QX[HRWV>M%4&'VUZA'V=EVI!0H)I;1G!Z+%KVYXN2 RMO@)WQO%Z+% M6H 'P@*L-.2'=S$:XLE<0?]+EK1-X+Q-]B//-X+E98?MPU$T1-DHNH*Q\D*[ M%&*?]<$Q9Y!,&$*0&3[SD\K%_ &U^\A-XE&V:!_*](-HE@ZVLFQ1L2",E$>4 MWSI$F.ICUV "&^TNK\'W$,>;,$1WP$)RT&Q(>S"<"5#T[U&0SMYKWD]"1J[L M#6+"2XE^BY_6!D\T8P=I3-OUQ'?1;W8^[J\EER(#+W26E. M.:F@R-\C=J71TCL.&,E2"F+I,HK,WGS**M_4R287Z2'GSX*U.&\S68,6P1"B M3%VQ4%\_<(,ESM\47/@E^V(%W5WK+(HE9G+<0FQ_/JN MPAIGBSM;[>QA,S+*YFO$:/B$-LBGQ6AO".D^6RZEIDN/R:6TRI;TN.3$.]_2 M4#94[5ECNYU%I>\7N M)-RFP]PPO1[< LTOZ TOBM8QBR8>1#LF M?7SL$MV^2_0&KN23^1&OQKZSTSHYJA\_:%]:GLO&"SMV*W(@7W_3<;']S$,A MBPV6!V3.;-ZT;TU&X01Y>,3VFHLP8A'8*F(!+- /#Y+"\7=I'X<^\\)90UP1 MS HP_WS$ L^\.3S*^TD*DR.W;?.\8)A&?D.W9(#XE,5"A'[Z%8A*V52?Y:V" MRM,?"E?*FO'TGJ4DERWEZ=U@K:P^W>!7/:7X$\W_H_*] MW^?\WU1PY6$)[7>]$7KUF-R3 H?^&D6?]KZ15V7&&O.8JY?.LEDXR^_UB,G[ MA)PUO-STZZ3ZWGET'295R2IHGP'+'V5TD%#W,:]&?.^R^-[G_^:QB!VD>[=H M]-A#F6^+A!\8]8%1_VB,XK=JO%N06J=)W99ZC_Z-H^$6VJ"0 M$0 '-G;6\M,C R,3 Q,C(N>'-DW59=;YLP%'W/K_!XG@.&I FH2:6UJC0I M^U#7JGV;#%R(5;"9;9KTW]_Y9']61G$V(2=^.,$T]D9X!.,0 MAV/JXVF:99"DD 5T\CZ/LNDD#KQQ@,/4PD;!"9XF(<$C,A[%*0D)"9+&Z5I% M*EE"29$1QE6T5C-GJ745N>YJM1JN@J&0N>M['G'O/BV^-5"GQ1:,W_?0ZU@6 M'3YP[71,%71PE9>B!U>4Y[04PT24KE7K$=]W$-5:LKC6<"ED>0$9K0L],*TUY L?$-E^XX_V) M'+9]/2Z'CG=\#HTS!#O!8V')I,.\BQ OQUVVC44*!9;)1U7/U:&JTPS"MC4YF\6GM#B M6.&&DM1%T^=_7KXY\(^5;RB,L_]"?27A6/6&HLS5\3O=M_QK,X]8.G/.A?D) M^$IS^#EPD 7<7'U\\;YI$CA [,)T@;8=FGOFXC4/PML?"8P:)K+4G>&IN\_= M\UHK2+_P>3/>KT)+;B&_(.[MG3?S^HON(*TU=E5NCV"W?P9OOG?.Z<:PN0+F M@R=02P,$% @ ]Z [4H/L1(V& 0 ZP( !4 !S9VUO+3(P,C$P,3(R M7V-A;"YX;6REDEUOVR 4AN_S*YAW.XRQG29822HMTZ1)F51EJ]I;#,/8)URNAM0M,L0:"%D4JWV^3V^V>\ M3JYWB\7F'<;W'X\'],F(AP&T1WL+W(-$H_(=NI/@3JBQ9D!WQI[4(\=X%S?M MS?G)JK;S*,]R^GO55G6SHE9R4N8:&39WSZ@Q^+2%/&&(G5"^K46^ L2\G]U\,WT<' L=+.FX;OE@4F$&$NID;^;?<,-;N"SFMJ.,?SK#-G%J./>77&>AF7/M8'!XWXSF M>3!__X8*^=60X+UXZ./Y#W/\K!7L_Z\WF#QH"3)X;3$Y\D%HF-;%/HOU^< J.% MJA?DQO(YY_7KQQ\ZT[M]4Z,GT$8H.?/HT/<0R%QQ(/7U1)]4_FV 6G10@.SP-%.V H]<#!K5&C5H >EU^*)83SO%BW4YEF+LK(H M\ /ZMJHG63&FHR =8Y;Y$8X@3G$:LP GO"@@YU"$;/REG!3). O].,0I=[(H M'.$D3RF.:!QEG*:4AGEG6@NYGK@A8P90>SAING#F5=9N)H3L=KOA/M/U4.F2 M!+X?DJ/:.\CW%_I=V*EIFJ:DJYZD1EP3MK:4//Y<_LXK:!@6TE@F\_\;M-MS M>UIX3A.3EV(K-6)BNO5+E3/;/<^'1T#O*ER$CS+L4I@&.*3#O>'>?(#0R\TQ MG6M5PPH*=)C>KWY48TFQJ.N4I#\2[]\<@. M*G8XGYT;N9FI:D%TOLT MUF0[H/WR'C-_7;FDQ=N?S[;UK9'XDOO7GE5PT2? M%WQAW0-M9X0;:#+0?:*^\CWC/$*^)726ALF2-6J8JX9T= O5MN%?K(33Y&-$ M4S8*N\;JTR#H6*ZXG &U+R^D<,UDV88'*[?[;6BPMR Y< \)/O-$FG(:CK@_ M#F@8^5 D69O)XR3R?9\58?+W.N24O&K>\\$_4$L#!!0 ( />@.U(?<,R^ M@@H ,Y> 5 &ULS5QM7\'F M?MF=J6(D)$"=-G>ZN>U.9W/;3IM.[^S.CD=O.$PQ9#!IDG^_$K838X.-P*9\ M::A].'K.8YYS=$#H]>\/\\3YJ?)%G*5OSN"Y>^:H5&0R3F=OSKY=OP?AV>\7 M+UZ\_AL ?_WSRY7S1R;NYBHMG,MS9WO6?XC_LD MN"A/NLQN'_-X=E,XR$5P^]O\%8\"Z",: ,9=#+ B%%#"$ AE%"DA5>2QX.7L M510&W'.)!Z@T9MCS02@H!!@2S"6D$'JB=)K$Z8]7YA_.%LK1P:6+\K]OSFZ* MXO;59')_?W_^P//D/,MG$^2ZWF1M?;8R?]BQO_=*:T@IG93?/IDNXCI#[19. M_OKSZJNX47,&XG11L%28 1;QJT7YX54F6%%R?A"7TVAA_@?69L!\!" "'CQ_ M6,BSBQ>.LZ0CSQ+U146.^?OMRX?&(>G$6$Q2-3._[&>5QYG\6K"\N&)<)1I] MZ:UXO%5OSA;Q_#91Z\]N"R,^SC]>#2XUSH_J-,#WABF-^3E!?4NE4-=NT]#]89^>L3'NBRR@B4# M7!;/PVQ 3LP'5_IH-8QQM">9EN.L4O<&5/50J%2J9;:LN'9B^>9,'TVEBJ?? M\[C0AI?9?'Z7QLO,O9B&..0XBD) *"< !Q@#AI@"+@M(Q)$OL">GQ=-%/54I M^/9U/7XYR($1SBQB*QHTFJM%=I>+Y^HV3^I*EJY6IKZ%DY3-U>*6K4[0,,U$ M8(G\8@72J:)\/7D.J N-R>G)24;%2R8J2!(S%FX>9FRBUDB!V(#J++$Z)=CVVM[# MZV&!'X>M$ZN\&U%68C_,0P_%[W$^F.P/![BI_1;6]@G@75K$Q>,'W>3FMUE> MYA/==Q1ZI+NTR!\O,ZFFH><)YC&M?Z@4P,+3#:FOJ'$0:B_$VTS08OQ MQI82EI"="N:73HE:T^RLD#L&>OL$T8;WPYGBR&R>.&4<@TBK!&)!3X],TF:4 MP5**1CY$>"1 M(KJ5P!)"99=8=L88:3)9X7SI&*3FXC=8;;/'+J%M,T8OFH;)$G8,=4@+C1ST M3@6[G@>6?V-HNY)O-K67^=83GWX^3$2K:APTK S5'WT&Z- MT\%DVQS0IF+W6/6LR:L_5W&JX#2D OJ^SP%7E %,(0$T\J&NSUC_Y*ZKRS3M M5)4W1QF;=+>KSNK ,6"=3ZGUS+Z.6,OJW)6N@>MS:Z:ZU^@Z)HY5I2N^?TV= MK@NOL5+7&G>HU4K(JX MF+MNX"+*7>7>$WJ?VEWG M=KCJO2>H2OW>9V1R5@5-KK@S^OVMD_SN2ZNJB[2.[BK_A=%<71D5XM09= MV]5+E6I'R8=4JH=_J\>I]'Q.?2R!RPD&V!<2<"@I@)[^XW(E(QG8M:I;(XQ- MB:OF:X72*6$Z&J=M>[I-9-O6M <]P[2E[9GIT(XV1-^[%=WV.W ;VA#6;@O: M9-A5SM?LX8/4/N-HM93EX]V4BL M#',J0ABZQ7(+R['RD2< M["C[#>+:*KT;'<.(NPT3'>2\&W)O!6^X'%BTN\'LZK3&QEZ:ZU>>KO6I4ZP8 M#+ F W.L91E ACE@>:&21X0[F'2>HWHIN.Q2?+I/2\#KKT:*UP=5F)7!DZL MPG;!6PFP+M(>XJNX&TQX=4%LBJ[V^ZZU\-UA=6NN]#UQE]X:X6W#WFW=_: L1OXZ+1$U%@(- M4 HB$7'S^J_6?^@3 *'0Q5= B:/6]7?;^=A$7X)RLLB!Z._\'\X:KOW3VB?V M#DN\#RTV['?81'M$\N!W\\NQU,W:/9'1M[D;[5-5^:NO\^8;.I M[Z. 4C\"Q+RECR,% 0VX![P@\GA$L"]5ZSO4%<]CD^<3.,>@:Z_**EV')=F9 MA!/KL67\5C*LC;6'!JO^!A-@;1B;ZJLWL)>>V48B^7R3I>N['S@@6'F>T"3X M"& L(Q"*@("(2E_8PUT&D0!!+YO@OV,.! M;F.I I0K/;L5'B8<=5IQO#70V"2[O93VZ56X->".JXZW^6W;R_9G;9AFM@-A MW1G@$8J "&FDE ]>Y:D]9K&YF'&GA268!V-MM,KQK7,6B:$SGP-G [:4M4] M&=0R<:Q44'7^:Q)!;8"-::#>VCX)7.?,[+'W]7'.LV2*N&Z*?<*!YR,78 @C M0"$E@ O=-8LPH-QOW3-7/(]-ZBMPSA)=>V57Z3HLYLXDG/H>5KOXK>1:&VL/ MA5;]#2;*VC V=5AOT'L'H ^+Q9W*-_>KP3ZCS!<0*&[4&' (*&41"#"2*,(4 M"=1Z3FR7BXVP*M$OU824?D\ 3B[L7=WWV"6HDY7B[!>T.\:OV M#&H,=L_.0N_N>LOMP'UU?5"[ M'76#79.$-WF_TD<7+]:?Q,L-T"]>_!]02P,$% @ ]Z [4F96["^P!@ MBS$ !4 !S9VUO+3(P,C$P,3(R7W!R92YX;6S5FMMNW#80AN_]%%OWMO3R M+-)(7+AN4AAU&R-QD:(W"QZ&:R&[DD')L?WV')"YG^//; M(6?$5S]?KE>SSY";LJY>;[,=NCV#*M2QK):OM_\Z>4O,]L][6UNO?B#D[U_> M'\U^KSS[6^5/YV1&RU__HH#Z[RN7R MM)UQRMG#NWG7IX)I;@OB/)5$@K+$*L>)B2E!B)"$*WY:[B93>$&5(#9VS:30 MQ 3+B&1*^L@L8R+TG:[*ZM-N]^)= S,<7-7T7U]OG[;MV>Y\?G%QL7/I\VJG MSLLYIU3,;UMOWS2_?-3^0O2MF;5VWM_]TK0IGVJ(W;+YWW\__K_>$]DXVKEFY=[X1Z/>_NSP]JI.'8+>'+!W2[[Z:].H/7VTVY/EM] MN7::(>&UY;HFW?Q2QGEG_,IE_=>@L0X,,]0(7*>5CU5Q<1RD7?\[YOVNQ"NP@J6LI,(*"+A'B*2%R4 MDA@M"Q>U]\[Y^UIT[C?H?S]3#82=9?UYCAWCC#';?2#=!T+9S3S]^,CHM5+/ M\_[V[WF";1<)P&M/"Z)"H8C4@'^:)#CQ2;L )H+F,(+S=VW>]_WN/._G,*MS MA(Q1YM:HR^'1G-\G_*;%_,QE[(B$TW(5;W_=A9LQYJVM1]#O>G+0W>T9CCI! MSA"/KN?FFX/K1]9B[(6^Y1CS?@RYK..;*OZ*P7GA70@%CY%8RP2J $!LDHZD M&&AR4D<5QJ#W2>.#2.#3)^'YBKXP$F^JMFROWL.R[)2HVC_=&OWW5 AE<.&D MT2#2(>!*2REATFO%(9HHTPA$/&5[$!!BND!LK.#C$S5T^JW,O_ ?4'Y?2 M\ZK-5P=UA 43PAJF(_$T8<0S 3#824$*05W0PB#"N!T>\$DN>+^\*(= %P/X/K_391)*J$)4Q@ MX),..'&X.!*&(PB.@E)RC-!QU^8P#"9<"GVV@"\\\=V3E=7Q:5W=IE@N.1Y! M 8E=\58:$8CCVA)'A5)4&Z_E&*GJ0[O# )AP!70C(5\8@H^Y;%NH#NKU^KRZ M2:,:W D%3*&DP12;6B(]%)A!44EH,AB]I @RC)&C/FE\& X3KG]N+ND+,_&A M7I6A;,MJ^0=N?'+I5@OKT&TEEK[%%AP8ZP+CRT/HV'" M] M4SE&HO%_?@S#9<)%SU&%?NDE!L(Y+I-7C/N3LEW!0H$U,@I'G.I$<9A.>ZH8 M"08\8]2%PH]Q!..AW6%03+C,N9&0+PS!27;=\;D/5VM?KQ9>(HW:%2,0<,_HL.F?<"GS^1).) "\N0RGKEI"?TB 86[$5>&) M+X(B4J *1CM!BH(5$(.WBM(1@\!=V\-(F'#%3$\NZ)C6(,4VF;2- N*1>$\:,2=! MR0%*EMWJ$+<^E[_#U:+P"2+(2"Q3*(IQ.!1$&P?@=5 "M.-Q-#X>&!]&QH3+ MEYM+^L),[.-N.'8[XK@ M.U))PPG?[A( "E: ? " 0 !L965C;VYS=6QT:6YG M86=R965M96YT9FEN86PN:'1M4$L! A0#% @ ]Z [4HW);/^=%P KJ8 M !$ ( !*Q, '-G;6\M,C R,3 Q,C(N:'1M4$L! A0#% M @ ]Z [4D-)FU.0 @ G@D !$ ( !]RH '-G;6\M,C R M,3 Q,C(N>'-D4$L! A0#% @ ]Z [4H/L1(V& 0 ZP( !4 M ( !MBT '-G;6\M,C R,3 Q,C)?8V%L+GAM;%!+ 0(4 Q0 ( />@ M.U(<>>0F"P( )T& 5 " 6\O !S9VUO+3(P,C$P,3(R M7V1E9BYX;6Q02P$"% ,4 " #WH#M2'W#,OH(* #.7@ %0 M @ &M,0 &UL4$L! A0#% @ ]Z [ M4F96["^P!@ BS$ !4 ( !8CP '-G;6\M,C R,3 Q,C)? =<')E+GAM;%!+!08 !P ' -